Business
ASP Isotopes Inc. Announces Changes to the Executive Management Teams of ASP Isotopes Inc. and Quantum Leap Energy LLC Effective October 2025
- ASP Isotopes Inc. appoints Interim CEO as Paul Mann becomes Executive Chairman. - Quantum Leap Energy LLC appoints Michael Cunniffe as CFO. - ASP Isotopes
About this update from Asp Isotopes Inc.
[{"type":"text","content":"- ASP Isotopes Inc. appoints Interim CEO as Paul Mann becomes Executive Chairman. - Quantum Leap Energy LLC appoints Michael Cunniffe as CFO. - ASP Isotopes Inc. provides information on upcoming investor events. WASHINGTON, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that, effective October 1, 2025, Paul Mann, the founder, Chairman and Chief Executive Officer of ASP Isotopes, will become Executive Chairman of ASP Isotopes and will be taking a temporary leave of absence from his Chief Executive Officer duties for health reasons. In consultation with Mr. Mann, and effective October 1, 2025, ASP Isotopes’ Board of Directors (the “Board”) appointed Robert Ainscow, the Company’s Chief Operating Officer, to serve as Interim Chief Executive Officer (principal executive officer), in addition to his current duties. In the Executive Chairman role, Mr. Mann has responsibility, working with the Interim Chief Executive Officer and the Board, for: the overall leadership and strategic direction of the Company; providing guidance and support to senior management of the Company; and the coordination of the activities of the Board. In the role of Interim CEO, Mr. Ainscow has the responsibility for managing the CEO’s direct reports and communications with the Company’s industry partners, shareholders and other important stakeholders, among other CEO duties. Mr. Mann underwent a planned orthopaedic surgery in the United States on September 19, 2025. While the procedure was successfully performed, the post-operative course was somewhat more complicated than initially anticipated. Although the course and timing of the recovery are not yet certain, Mr. Mann has been advised that his recovery could take several months, during which time he will be unable to travel. The Company wishes Mr. Mann a full and speedy recovery. Mr. Ainscow co-founded ASP Isotopes with Mr. Mann in 2021 and has worked alongside Mr. Mann for the past four years. Mr. Ainscow has been the Company’s Chief Operating Officer since its inception, and serves as Chief Executive Officer of the Company’s operating subsidiaries, ASP Isotopes South Africa (Pty) Ltd, ASP Is...